Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. - Wikidata - awgldk - TriplyDB

Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.

Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.

http://www.wikidata.org/entity/Q38356248

about

Aptamers: A promising chemical antibody for cancer therapy Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems Nucleic acid aptamers: an emerging frontier in cancer therapy DNA Aptamers in the Diagnosis and Treatment of Human Diseases Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical science Aptamer-Mediated Targeted Delivery of Therapeutics: An Update Aptamer-Drug Conjugates Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer A human anti-c-Met Fab fragment conjugated with doxorubicin as targeted chemotherapy for hepatocellular carcinoma A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549)DNA-aptamer targeting vimentin for tumor therapy in vivo.Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.A U87-EGFRvIII cell-specific aptamer mediates small interfering RNA delivery.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy Aptamer-targeted antigen delivery.Aptamer-incorporated hydrogels for visual detection, controlled drug release, and targeted cancer therapy Recent developments in protein and cell-targeted aptamer selection and applications Progress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges.Aptamers selected by cell-SELEX for application in cancer studies.Hybrid compounds: from simple combinations to nanomachines.Bioengineering strategies for designing targeted cancer therapies Synthetic aptamer-polymer hybrid constructs for programmed drug delivery into specific target cells Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo.Cell-specific aptamer-mediated targeted drug delivery Aptamer photoregulation in vivo Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine Near-infrared light-responsive core-shell nanogels for targeted drug delivery.Aptamers: active targeting ligands for cancer diagnosis and therapy Prodrugs for improving tumor targetability and efficiency.Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole.Tumor-targeted drug delivery with aptamers Smart multifunctional nanostructure for targeted cancer chemotherapy and magnetic resonance imaging.Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX.Aptamer technology for tracking cells' status & function.

P2860

Q26766832-A9FB6E6A-F37F-45EC-A97C-2546CACA577E Q26782485-CA3659F6-D12A-4383-B234-F7601B7F9263 Q26849947-4DE97EB1-95C1-46C2-AA12-179A7618CE85 Q26864314-57571CB0-BF46-4DAB-9B1A-F88CC2E58D44 Q26995510-0C4B4B81-3119-4994-8076-75543D17E9A3 Q28066827-D4402949-8ABF-4350-B3D6-D908D2902CD4 Q28468281-88F11331-A08F-4727-BF35-69F693778F4B Q28476756-A8772F4B-9ED3-46C8-996F-76D8F394062D Q28481099-C1B651ED-0A30-4A06-84B6-252689AAC2E4 Q28482911-B1D3E02B-923E-4014-B7FF-4A86B451B373 Q28487973-9BD61A1D-B4FD-4F9D-A97A-89D7EACA65CC Q28550592-4F7D73A0-2562-4337-866C-BF3877692E22 Q28829762-33FC238A-13D1-4399-861F-9945EFD3E64D Q30415521-AB900D61-3FBD-44D6-B605-BB8DB89A2D65 Q30434521-252BC025-C0A1-4327-89F6-5C83BB98E312 Q33578254-7744AC78-4A03-46B8-A0B7-F74CCE7956A9 Q33598723-E25824DF-E27D-491D-85DA-9FF6B0E85F26 Q33733546-2CFF6FD5-7457-4A49-A0D9-3C516B57B362 Q33834772-37F0079E-FE00-4953-98AC-5DC912E91A25 Q33870736-B829EBC9-C6F9-4F21-B9A6-4414BDEF61AB Q33901924-EED10735-2CA5-490E-8AAE-D85FAB890B38 Q33908491-5B4FFD29-9D3C-4F06-8612-7B84C7F08755 Q33935498-FB5DBCAD-C026-4009-9F1C-F463D45CA144 Q34006173-E520F9BC-E579-4887-A6B1-6B9169421EBA Q34125590-4610953D-D5EA-4968-BD70-B76AEC4B1D9A Q34194191-4497270F-B36B-4FD5-BB88-939D0440E0C1 Q34408096-A0D0FE5A-C68D-4460-ACE1-15B1A0ECAD81 Q34550075-952C3CDF-86AE-45A5-B6DB-4163386ECCAE Q34599718-D24379D1-DC47-41BF-B724-DCC1FAD28501 Q34661329-98212C3C-4B44-44CE-9810-50057F40B5F0 Q34698624-3E23E59B-FCBB-46B6-A364-D04318A75D42 Q35074514-09064751-6CB5-45A0-AF3C-6ABD1873000E Q35086493-924D175A-B702-41BF-95D0-DFE1F2D26266 Q35095165-F4466A48-7146-4342-9B2C-FCB77949A5C9 Q35180943-09C1A6FB-4D96-4FD6-A47F-720F534FAA23 Q35237773-8D9F0AF4-7747-473A-8760-EB578581BA60 Q35490874-B518304C-9995-4645-A204-FA28B0EE1651 Q35590324-6596532C-EFE2-49AA-A3F0-07A9193DCB99 Q35621766-5CDE4058-C95F-409B-BA21-C442C9A2D167 Q35673895-C7CEA0C5-1552-4B52-8E53-FEAD92841041

P2860

Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.

http://www.wikidata.org/entity/Q38356248

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Molecular assembly of an aptam ...... drug delivery to tumor cells.

@en

type

label

Molecular assembly of an aptam ...... drug delivery to tumor cells.

@en

prefLabel

Molecular assembly of an aptam ...... drug delivery to tumor cells.

@en

P1433

Q38356248-2AFAB693-CF62-49EE-A3D6-1E0B4EB7A5E2

P1476

Q38356248-C77A63D8-F2B8-44FF-912F-7EC626846152

P2093

Q38356248-0903076B-17B4-4732-A3D4-FB940E9692C1

Q38356248-4DBF8533-FD58-4CCA-887B-8F8B8B0460D7

Q38356248-6DF8E7E7-F89F-486E-97DB-9006DDE2F5EC

Q38356248-A34672ED-DE68-4C13-A774-FFDFC12AB0FF

Q38356248-D62D3A0E-C4E8-4235-B28D-ACEB225300F6

Q38356248-E60DC64C-DDC2-4214-BE48-71E461D4B84A

Q38356248-E85350A5-C8EC-43F4-9EBB-2AFA3048FCCF

P2860

Q38356248-0493E1C7-9D92-489B-AEF1-4EB3AF24C932

Q38356248-1CE1DBEB-FBDD-4791-88E1-495A403449AF

Q38356248-25688440-A21D-4471-A8A8-F3174F3E1D7E

Q38356248-401CE5C9-F88D-4492-A5AD-0EEB7795ABDF

Q38356248-40F277E9-6CC4-4169-94AD-F1A05C6B2A8C

Q38356248-506DC648-0011-404C-B009-F998CDB6ADC9

Q38356248-62A022E6-1D01-438D-AB0F-00E83D84E887

Q38356248-7B46AD10-8B23-493D-9512-82C4C870BD3F

Q38356248-9958DEFF-F739-499E-8343-27D45A231FA8

Q38356248-9B884010-1CCC-45C0-B305-518596F9157B

P304

Q38356248-1C86F363-253E-48FE-B3F7-F81A8CF3D89D

P31

Q38356248-C02DF4E5-5ECF-4782-A22A-75EB72313620

P356

Q38356248-9FC0EB25-F7A4-4550-B734-9F367F61A370

P433

Q38356248-D9B7A920-D5D2-4E8E-B0F1-B37BC90FEB70

P478

Q38356248-C09F11C6-EC20-4959-B488-DD9B6BC000B9

P577

Q38356248-DB47586E-3CB2-44EB-9C61-0F43BC33AA24

P5875

Q38356248-198F4734-CCC8-44DD-BDA0-71B98E05FA9E

P698

Q38356248-2614F5CA-0C09-4DFB-984D-DF3752485A21

P921

Q38356248-D28E6010-B2AF-401F-BCBB-F6ED0059B8CE

P932

Q38356248-5D738C7C-321E-4281-8F95-DE9B5ED73C36

P356

P1433

P1476

Molecular assembly of an aptam ...... drug delivery to tumor cells.

@en

P2093

Dihua Shangguan

http://www.w3.org/2001/XMLSchema#string

Haipeng Liu

http://www.w3.org/2001/XMLSchema#string

Joseph A Phillips

http://www.w3.org/2001/XMLSchema#string

Weihong Tan

http://www.w3.org/2001/XMLSchema#string

Xiaoling Zhang

http://www.w3.org/2001/XMLSchema#string

Yan Chen

http://www.w3.org/2001/XMLSchema#string

Yu-Fen Huang

http://www.w3.org/2001/XMLSchema#string

P2860

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

In vitro selection of RNA molecules that bind specific ligands

Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions.

Aptamers evolved from live cells as effective molecular probes for cancer study.

Progress in immunoconjugate cancer therapeutics.

Nanoparticle-aptamer bioconjugates for cancer targeting.

Targeted cancer therapy: conferring specificity to cytotoxic drugs.

Antibody-drug conjugates for cancer therapy.

pH and the recycling of transferrin during receptor-mediated endocytosis.

P304

862-868

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CBIC.200800805

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24170360

http://www.w3.org/2001/XMLSchema#string

P698

19253922

http://www.w3.org/2001/XMLSchema#string

P921

P932

2992821

http://www.w3.org/2001/XMLSchema#string